Ascendis Pharma AS (ASND) — Net Asset Quality Index
Ascendis Pharma AS (ASND) has a Net Asset Quality Index of 24.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $2.01 Billion minus total liabilities of $1.52 Billion yields net assets of $488.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check ASND asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ascendis Pharma AS Net Asset Quality Index Over Time (2011–2025)
This chart shows how Ascendis Pharma AS's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 24.4%, representing net assets of $488.48 Million against total assets of $2.01 Billion USD. See Ascendis Pharma AS current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Ascendis Pharma AS (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Ascendis Pharma AS from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ascendis Pharma AS (ASND) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -12.5% | $-162.75 Million | $1.30 Billion | $1.46 Billion | ▼ -3.5 pp |
| 2024 | -9.0% | $-105.71 Million | $1.18 Billion | $1.29 Billion | ▲ +8.7 pp |
| 2023 | -17.6% | $-145.70 Million | $825.59 Million | $971.28 Million | ▼ -41.8 pp |
| 2022 | 24.2% | $263.35 Million | $1.09 Billion | $826.39 Million | ▼ -57.3 pp |
| 2021 | 81.4% | $883.63 Million | $1.08 Billion | $201.29 Million | ▼ -4.2 pp |
| 2020 | 85.6% | $838.71 Million | $979.79 Million | $141.08 Million | ▼ -2.6 pp |
| 2019 | 88.2% | $597.11 Million | $676.73 Million | $79.62 Million | ▲ +0.4 pp |
| 2018 | 87.8% | $280.05 Million | $318.97 Million | $38.92 Million | ▼ -0.9 pp |
| 2017 | 88.7% | $187.21 Million | $210.98 Million | $23.77 Million | ▼ -4.2 pp |
| 2016 | 92.9% | $176.61 Million | $190.07 Million | $13.46 Million | ▲ +1.6 pp |
| 2015 | 91.3% | $120.33 Million | $131.77 Million | $11.45 Million | ▲ +13.2 pp |
| 2014 | 78.1% | $45.81 Million | $58.67 Million | $12.86 Million | ▲ +54.5 pp |
| 2013 | 23.6% | $6.30 Million | $26.70 Million | $20.40 Million | ▲ +17.5 pp |
| 2012 | 6.1% | $1.56 Million | $25.41 Million | $23.85 Million | ▲ +5.1 pp |
| 2011 | 1.0% | $233.00K | $22.82 Million | $22.59 Million | — |